Bernard Bonnotte

Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials

Florence Delestre, Pierre Charles, Alexandre Karras et al. · Annals of the Rheumatic Diseases · 2023 · 50 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Sara Thietart, Alexandre Karras, Jean‐François Augusto et al. · JAMA Network Open · 2022 · 44 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis

Xavier Puéchal, Michele Iudici, Élodie Perrodeau et al. · JAMA Network Open · 2022 · 39 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry

Xavier Puéchal, Michele Iudici, Christian Pagnoux et al. · RMD Open · 2022 · 25 citations · Full text

Life Sciences, Immunology, Pathology +17

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients

Loı̈c Guillevin, Christian Pagnoux, Alexandre Karras et al. · La Presse Médicale · 2013 · 21 citations

Medicine, Immunology, Internal Medicine +10